BCO trades 47.8% below Wall Street's consensus target of $163.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes BCO achieves its forward estimates and maintains a stable P/E multiple of 12.3x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, The Brink's Company (BCO) has a Wall Street consensus price target of $163.00, based on estimates from 9 covering analysts. With the stock currently trading at $110.25, this represents a potential upside of +47.8%. The company has a market capitalization of $4.54B.
Analyst price targets range from a low of $163.00 to a high of $163.00, representing a 0% spread in expectations. The median target of $163.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, BCO trades at a trailing P/E of 28.8x and forward P/E of 12.3x. The forward PEG ratio of 0.21 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +105.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $135.56, with bear and bull scenarios of $85.40 and $178.61 respectively. Model confidence stands at 43/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 ARMKAramark | $13.8B | $52.54 | $69.20 | +31.7% | Buy | 23.1x | 24 |
 ABMABM Industries Incorporated | $3.1B | $52.90 | $51.88 | -1.9% | Hold | 13.2x | 12 |
 ALLEAllegion plc | $15.8B | $185.39 | $181.50 | -2.1% | Hold | 20.4x | 24 |
 CTASCintas Corporation | $89.0B | $222.36 | $234.17 | +5.3% | Hold | 40.1x | 30 |
 DBDDiebold Nixdorf, Incorporated | $2.0B | $58.27 | $100.00 | +71.6% | Buy | 12.5x | 13 |
 NATLNCR Atleos Corporation | $3.5B | $47.18 | $42.47 | -10.0% | Hold | 9.8x | 4 |
 VRRMVerra Mobility Corporation | $333M | $2.19 | $6.50 | +196.8% | Hold | 1.9x | 12 |
 BACBank of America Corporation | $350.7B | $49.42 | $66.00 | +33.5% | Buy | 11.3x | 54 |
 WFCWells Fargo & Company | $256.9B | $83.94 | $94.86 | +13.0% | Buy | 11.4x | 60 |
 SWKStanley Black & Decker, Inc. | $17.3B | $114.85 | $98.25 | -14.5% | Hold | 20.5x | 37 |
Quick answers to the most common questions about buying BCO stock.
The consensus Wall Street price target for BCO is $163, representing 47.8% upside from the current price of $110.25. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
BCO has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $163 implies 47.8% upside from current levels.
With a forward P/E of 12.2944x, BCO trades at a relatively low valuation. The consensus target of $163 implies 47.8% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $163 for BCO, while the most conservative target is $163. The consensus of $163 represents the median expectation. Our quantitative valuation model projects a bull case target of $179 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
BCO is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 3 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month BCO stock forecast based on 9 Wall Street analysts shows a consensus price target of $163, with estimates ranging from $163 (bear case) to $163 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $136, with bear/bull scenarios of $85/$179.
Our quantitative valuation model calculates BCO's fair value at $136 (base case), with a bear case of $85 and bull case of $179. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 43/100.
BCO trades at a forward P/E ratio of 12.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 28.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on BCO, with a "Buy" consensus rating and $163 price target (47.8% upside). 6 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
BCO analyst price targets range from $163 to $163, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $163 consensus represents the middle ground. Our model's $85-$179 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.